|
000
| 02081nam 22003378a 4500 |
|---|
| 001 | 9.830850 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107145623 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 170119s2017 onc o f000 0 eng d |
|---|
| 020 | |a978-0-660-07290-6 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-157/1-2017E-PDF |
|---|
| 245 | 00|aUpdated recommendations on human papillomavirus (HPV) vaccines |h[electronic resource] : |b9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. |
|---|
| 246 | 1 |iAt head of title: |aAdvisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) |
|---|
| 246 | 30|a9-valent HPV vaccine 2-dose immunization schedule |
|---|
| 260 | |a[Ottawa] : |bPublic Health Agency of Canada, |c2017. |
|---|
| 300 | |a29 p. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |aIssued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations immunodéprimées. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"Human papillomavirus (HPV) infections are the most common sexually transmitted infections. There are over 100 types of HPV, and they are broadly classified into high and low risk types"--Summary, p. 3. |
|---|
| 692 | 07|2gccst|aSexually transmitted diseases |
|---|
| 692 | 07|2gccst|aImmunization |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |
|---|
| 775 | 08|tRecommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) |w(CaOODSP)9.830853 |
|---|
| 856 | 40|qPDF|s332 KB|uhttps://publications.gc.ca/collections/collection_2017/aspc-phac/HP40-157-1-2017-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/healthy-living/updated-recommendations-human-papillomavirus-immunization-schedule-immunocompromised-populations.html |
|---|